ArQule Strikes Deal With Japan's Daiichi | November 17, 2008 Issue - Vol. 86 Issue 46 | Chemical & Engineering News
Volume 86 Issue 46 | p. 27 | Concentrates
Issue Date: November 17, 2008

ArQule Strikes Deal With Japan's Daiichi

Department: Business

ArQule has sealed two deals with Japanese drugmaker Daiichi Sankyo. In the first agreement, Daiichi will pay $60 million up front, as well as undisclosed milestone and royalty payments, for access to ArQule's ARQ 197, a small molecule that blocks Met, a protein implicated in some cancers. Separately, Daiichi will fork over $15 million plus research funding to use ArQule's kinase inhibitor discovery platform to find new anticancer drugs. The firms have launched a research collaboration that has already selected two kinase targets.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment